HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers.

AbstractBACKGROUND:
Human immunodeficiency virus (HIV)--infected individuals maintaining plasma HIV RNA levels <75 copies/mL in the absence of therapy ("HIV controllers") often maintain high HIV-specific T cell responses, which likely contribute to the control of viral replication. Despite robust immune responses, these individuals never eradicate HIV infection. We hypothesized that HIV-specific CD4(+) T cells might serve as target cells for HIV, contributing to viral persistence in this setting.
METHODS:
We measured frequencies of activated (CD38(+) HLA-DR(+)) and HIV Gag-specific CD4(+) and CD8(+) T cells and plasma- and cell-associated levels of HIV RNA and DNA in a cohort of 38 HIV controllers.
RESULTS:
Although there was no evidence of a relationship between the extent of low-level viremia and the frequency of either activated or HIV-specific CD4(+) T cells, controllers with higher HIV-specific CD4(+) T cell frequencies had higher cell-associated HIV DNA levels (ρ = 0.53; P = .019). Higher activated CD4+ T cell frequencies were also associated with higher levels of cell-associated DNA (P = .027) and RNA (P = .0096). However, there was no evidence of a relationship between cell-associated HIV RNA or DNA levels and HIV-specific CD8(+) T cell frequencies.
CONCLUSIONS:
These data support a model in which strong HIV-specific CD4(+) T cell responses in HIV controllers, while contributing to a potent adaptive immune response, may also contribute to viral persistence, preventing the natural eradication of HIV infection.
AuthorsPeter W Hunt, Hiroyu Hatano, Elizabeth Sinclair, Tzong-Hae Lee, Michael P Busch, Jeffrey N Martin, Joseph M McCune, Steven G Deeks
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 52 Issue 5 Pg. 681-7 (Mar 01 2011) ISSN: 1537-6591 [Electronic] United States
PMID21245154 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Viral
  • HLA-DR Antigens
  • RNA, Viral
  • gag Gene Products, Human Immunodeficiency Virus
  • ADP-ribosyl Cyclase 1
Topics
  • ADP-ribosyl Cyclase 1 (analysis)
  • Adult
  • CD4-Positive T-Lymphocytes (immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • DNA, Viral (blood)
  • Female
  • HIV (immunology)
  • HIV Infections (immunology)
  • HIV Long-Term Survivors
  • HLA-DR Antigens (analysis)
  • Humans
  • Male
  • Middle Aged
  • RNA, Viral (blood)
  • Viral Load
  • gag Gene Products, Human Immunodeficiency Virus (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: